factual

What was the total value of Best Brains' cash and cash equivalents on December 31, 2024?

Best_Brains Franchise · 2025 FDD

Answer from 2025 FDD Document

tances, but not for the purpose of expressing an opinion on the effectiveness of Best Brains Inc's internal control. Accordingly, no such opinion is expressed.

  • Evaluate the appropriateness of accounting policies used and the reason

Source: Item 21 — FINANCIAL STATEMENTS (FDD page 42)

What This Means (2025 FDD)

According to Best Brains' 2025 Franchise Disclosure Document, the company's cash and cash equivalents totaled $219,342 as of December 31, 2024. This figure represents the amount of readily available funds Best Brains had at its disposal on that specific date. Cash and cash equivalents are considered current assets, which are assets that can be converted into cash within one year.

For a prospective franchisee, this number provides insight into the financial health and liquidity of Best Brains. A higher cash and cash equivalents balance generally indicates a stronger ability to meet short-term obligations and invest in future growth. However, it is essential to consider this figure in conjunction with other financial metrics, such as liabilities and overall profitability, to gain a comprehensive understanding of the company's financial standing.

It is also worth noting that the cash and cash equivalents balance can fluctuate due to various factors, including revenue, expenses, and investments. Therefore, it is advisable for potential franchisees to review Best Brains' financial statements for multiple years to identify any trends or patterns in its cash position. Comparing the cash and cash equivalents from 2024 ($219,342) to 2023 ($285,979) shows a decrease in cash and cash equivalents year over year.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.